| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1986PNAS...83.8206M |
| P356 | DOI | 10.1073/PNAS.83.21.8206 |
| P932 | PMC publication ID | 386896 |
| P698 | PubMed publication ID | 3022285 |
| P5875 | ResearchGate publication ID | 20134566 |
| P2093 | author name string | T Endo | |
| J Massagué | |||
| B Nadal-Ginard | |||
| S Cheifetz | |||
| P2860 | cites work | Cloning and characterization of cDNA sequences corresponding to myosin light chains 1, 2, and 3, troponin-C, troponin-T, alpha-tropomyosin, and alpha-actin | Q24300858 |
| High resolution two-dimensional electrophoresis of proteins | Q24608190 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid | Q26778512 | ||
| The correlation between the synthesis of skeletal muscle actin, myosin heavy chain, and myosin light chain and the accumulation of corresponding mRNA sequences during myogenesis | Q28280999 | ||
| cDNA clone analysis of six co-regulated mRNAs encoding skeletal muscle contractile proteins | Q30450035 | ||
| Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro | Q35610349 | ||
| Effect of fibroblast growth factor on the division and fusion of bovine myoblasts | Q36198441 | ||
| Serum contains a platelet-derived transforming growth factor | Q36310452 | ||
| New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues | Q36366470 | ||
| Retention of differentiation potentialities during prolonged cultivation of myogenic cells | Q36475611 | ||
| Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype | Q36913110 | ||
| Type beta transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts | Q37540043 | ||
| Type beta transforming growth factor: a bifunctional regulator of cellular growth | Q37672515 | ||
| Inhibition of myoblast differentiation in vitro by a protein isolated from liver cell medium | Q41441265 | ||
| Reversibility of muscle differentiation in the absence of commitment: analysis of a myogenic cell line temperature-sensitive for commitment | Q42798649 | ||
| Cellular distribution of type I and type II receptors for transforming growth factor-beta | Q42811181 | ||
| Stimulation by insulin-like growth factors is required for cellular transformation by type beta transforming growth factor | Q42815876 | ||
| Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines | Q42816156 | ||
| Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes | Q42820082 | ||
| Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix | Q43755354 | ||
| Epidermal growth factor-like transforming growth factor. I. Isolation, chemical characterization, and potentiation by other transforming factors from feline sarcoma virus-transformed rat cells | Q45795179 | ||
| Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. | Q51278213 | ||
| Transforming growth factor production by chemically transformed cells | Q52826927 | ||
| Metabolic changes in the extracellular matrix during differentiation of myoblasts of the L6 line and of a Myo- non-fusing mutant. | Q54434625 | ||
| Fibronectin delays the fusion of L6 myoblasts | Q66972330 | ||
| Changes in protein synthesis during myogenesis in a clonal cell line | Q66985186 | ||
| Subunit structure of a high-affinity receptor for type beta-transforming growth factor. Evidence for a disulfide-linked glycosylated receptor complex | Q70086167 | ||
| Transient induction of poly(A)-short myosin heavy chain messenger RNA during terminal differentiation of L6E9 myoblasts | Q71368882 | ||
| Regulation of muscle gene expression. The accumulation of messenger RNAs coding for muscle-specific proteins during myogenesis in a mouse cell line | Q71863644 | ||
| Growth Inhibitor from BSC-1 Cells Closely Related to Platelet Type β Transforming Growth Factor | Q72399491 | ||
| Transcriptional and cell cycle-mediated regulation of myosin heavy chain gene expression during muscle cell differentiation | Q72709328 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8206-8210 | |
| P577 | publication date | 1986-11-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Type beta transforming growth factor is an inhibitor of myogenic differentiation | |
| P478 | volume | 83 |
| Q28592424 | A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts, allowing skeletal muscle differentiation |
| Q36733602 | A phorbol ester-regulated ribonuclease system controlling transforming growth factor beta 1 gene expression in hematopoietic cells |
| Q36766046 | A ras-dependent pathway abolishes activity of a muscle-specific enhancer upstream from the muscle creatine kinase gene |
| Q39649999 | APOBEC2, a selective inhibitor of TGFβ signaling, regulates left-right axis specification during early embryogenesis. |
| Q41357555 | Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters |
| Q91714852 | Adipose Tissue-Derived Stromal Cells in Matrigel Impacts the Regeneration of Severely Damaged Skeletal Muscles |
| Q45169255 | Altered serum transforming growth factor-beta1 and monocyte chemoattractant protein-1 levels in obstructive jaundice |
| Q28579193 | Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding |
| Q34377653 | An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal |
| Q39348417 | An inhibitor of transforming growth factor beta type I receptor ameliorates muscle atrophy in a mouse model of caveolin 3-deficient muscular dystrophy |
| Q36763391 | An internal regulatory element controls troponin I gene expression |
| Q28284898 | Analysis of the native murine bone morphogenetic protein serine threonine kinase type I receptor (ALK-3) |
| Q45237789 | Autocrine and Paracrine Regulation of Myocardial Cell Growth in Vitro The TGFβ Paradigm |
| Q41031197 | Autocrine secretion of TGF-beta 1 and TGF-beta 2 by pre-adipocytes and adipocytes: a potent negative regulator of adipocyte differentiation and proliferation of mammary carcinoma cells |
| Q41541840 | Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures |
| Q59313499 | Bone biopsy and densitometry findings in a child with Camurati–Engelmann disease |
| Q36324476 | Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes |
| Q28261235 | Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells |
| Q36235105 | Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage |
| Q41331286 | Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells |
| Q47289368 | Ca2+ channel regulation by transforming growth factor-beta 1 and bone morphogenetic protein-2 in developing mice myotubes |
| Q41087362 | Calpain and calpastatin in myoblast differentiation and fusion: effects of inhibitors |
| Q38337612 | Calpastatin-modulation of m-calpain activity is required for myoblast fusion |
| Q24655306 | Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment |
| Q34628985 | Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand |
| Q30442323 | Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells |
| Q36219249 | Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture |
| Q73043386 | Cellular localisation of transforming growth factor-beta 2 and -beta 3 (TGF-beta2, TGF-beta3) in damaged and regenerating skeletal muscles |
| Q41552788 | Cellular localization of muscle and nonmuscle actin mRNAs in chicken primary myogenic cultures: the induction of alpha-skeletal actin mRNA is regulated independently of alpha-cardiac actin gene expression |
| Q69648716 | Cellular origin and distribution of transforming growth factor-beta in the normal rat myocardium |
| Q54777436 | Chicken quantitative trait loci for growth and body composition associated with transforming growth factor-beta genes |
| Q34433454 | Conditional TGF-β1 treatment increases stem cell-like cell population in myoblasts |
| Q35032908 | Control of differentiation in BC3H1 muscle cells |
| Q39581697 | Control of myogenic differentiation by cellular oncogenes |
| Q33840167 | Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation |
| Q24672178 | Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3 |
| Q34464097 | Cytokines in exertion-induced skeletal muscle injury |
| Q64934091 | Cytoplasmic sequestration of the RhoA effector mDiaphanous1 by Prohibitin2 promotes muscle differentiation. |
| Q72910009 | Degeneration of skeletal and cardiac muscles in c-myb transgenic mice |
| Q90053613 | Deletion of metal transporter Zip14 (Slc39a14) produces skeletal muscle wasting, endotoxemia, Mef2c activation and induction of miR-675 and Hspb7 |
| Q67841855 | Development regulation of the subcellular distribution and glycosylation of GLUT1 and GLUT4 glucose transporters during myogenesis of L6 muscle cells |
| Q36218963 | Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes |
| Q28581030 | Differential adaptation of growth and differentiation factor 8/myostatin, fibroblast growth factor 6 and leukemia inhibitory factor in overloaded, regenerating and denervated rat muscles |
| Q41587723 | Differential effects of fibroblast growth factor and tumor promoters on the initiation and maintenance of adipocyte differentiation |
| Q34573676 | Differential expression of transforming growth factors alpha and beta in rat intestinal epithelial cells |
| Q33790096 | Differential regulation of skeletal alpha-actin transcription in cardiac muscle by two fibroblast growth factors |
| Q41674323 | Differential response of embryonic and fetal myoblasts to TGFβ: a possible regulatory mechanism of skeletal muscle histogenesis |
| Q42816379 | Differentiation and cell surface expression of transforming growth factor-beta receptors are regulated by interaction with matrix collagen in murine osteoblastic cells |
| Q36219644 | Differentiation of cardiac myocytes after mitogen withdrawal exhibits three sequential states of the ventricular growth response |
| Q41552587 | Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone |
| Q34245224 | Dihydropyridine receptor gene expression is regulated by inhibitors of myogenesis and is relatively insensitive to denervation |
| Q38991463 | Diseases of the Nucleoskeleton. |
| Q33832595 | Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins |
| Q37042957 | Early and Late Events in the Development of Human Breast Cancer |
| Q41450893 | Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators |
| Q36402584 | Effect of genetic background on the dystrophic phenotype in mdx mice. |
| Q41709531 | Effect of transforming growth factor-beta 1 and -beta 2 on the proliferation of Burkitt lymphoma and lymphoblastoid cell lines |
| Q38617187 | Effects of growth factors on myogenic differentiation |
| Q44359592 | Effects of transforming growth factor beta 1 on astroglial cells in culture |
| Q35259539 | Emerin in health and disease |
| Q36786710 | Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. |
| Q59005161 | Enhanced myogenesis in NCAM-transfected mouse myoblasts |
| Q42209163 | Ethyl-3,4-dihydroxybenzoate inhibits myoblast differentiation: evidence for an essential role of collagen |
| Q47170895 | Expression Profiling of Differentiating Emerin-Null Myogenic Progenitor Identifies Molecular Pathways Implicated in Their Impaired Differentiation. |
| Q35048478 | Expression and methylation of FGF2, TGF-β and their downstream mediators during different developmental stages of leg muscles in chicken |
| Q41736383 | Expression of PDGF A-chain and beta-receptor genes during rat myoblast differentiation |
| Q55333548 | Expression of Transforming Growth Factor-β1 mRNA in Human Hepatocellular Carcinoma |
| Q36794671 | Expression of the MyoD1 muscle determination gene defines differentiation capability but not tumorigenicity of human rhabdomyosarcomas |
| Q42515247 | Expression of transforming growth factor beta in the embryonic avian lens coincides with the presence of mitochondria. |
| Q35832578 | Expression of transforming growth factor-beta isoforms in small round cell tumors of childhood. An immunohistochemical study |
| Q36759579 | Fibroblast growth factor and transforming growth factor beta repress transcription of the myogenic regulatory gene MyoD1 |
| Q34082922 | Fluid shear stress regulates the expression of TGF-beta1 and its signaling molecules in mouse embryo mesenchymal progenitor cells |
| Q46299593 | Formation of new myotubes occurs exclusively at the multiple innervation zones of an embryonic large muscle |
| Q69964487 | Further purification of a fibroblast growth factor-like factor from chick embryo extract by heparin-affinity chromatography |
| Q28262319 | GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration |
| Q37481185 | Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions |
| Q36217368 | Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor |
| Q41578070 | Growth factors that repress myoblast differentiation sustain phosphorylation of a specific site on histone H1 |
| Q24643379 | H36-alpha 7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis |
| Q34365343 | Heart tumors specifically induced in young avian embryos by the v-myc oncogene |
| Q37375446 | Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice |
| Q39160093 | Homeodomain-interacting protein kinase 2-dependent repression of myogenic differentiation is relieved by its caspase-mediated cleavage |
| Q52714547 | Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches. |
| Q38078019 | Hypothalamic amenorrhea in a Camurati-Engelmann disease--a case report |
| Q34994347 | Identification of differentially regulated secretome components during skeletal myogenesis |
| Q33770085 | Identification of retinoic acid in a high content screen for agents that overcome the anti-myogenic effect of TGF-beta-1. |
| Q45918285 | Identification of secreted proteins associated with obesity and type 2 diabetes in Psammomys obesus. |
| Q42933528 | Immunoneutralization of TGFbeta1 Improves Skeletal Muscle Regeneration: Effects on Myoblast Differentiation and Glycosaminoglycan Content |
| Q41401161 | In vitro differentiation and proliferation in a newly established human rhabdomyosarcoma cell line |
| Q62661527 | In vivo GDF3 administration abrogates aging related muscle regeneration delay following acute sterile injury |
| Q36236452 | Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype |
| Q37117914 | Inhibition of mammalian muscle differentiation by regeneration blastema extract of Sternopygus macrurus |
| Q40649982 | Isolation and characterization of a variant myoblast cell line that is temperature sensitive for differentiation |
| Q34273959 | Loss of emerin alters myogenic signaling and miRNA expression in mouse myogenic progenitors |
| Q33588122 | MAPK signaling pathways and HDAC3 activity are disrupted during differentiation of emerin-null myogenic progenitor cells |
| Q89599207 | Maintenance of the Undifferentiated State in Myogenic Progenitor Cells by TGFβ Signaling is Smad Independent and Requires MEK Activation |
| Q35608635 | Mapping of the ligand binding domain of the transforming growth factor beta receptor type III by deletion mutagenesis |
| Q44626931 | Mechanisms in TGF-β Action |
| Q24679265 | Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta |
| Q39847891 | Menin expression modulates mesenchymal cell commitment to the myogenic and osteogenic lineages |
| Q37917718 | Mesoangioblasts of inclusion-body myositis: a twofold tool to study pathogenic mechanisms and enhance defective muscle regeneration |
| Q46347064 | Mesodermal cell determination and differentiation |
| Q30450392 | Mitogen stimulation affects contractile protein mRNA abundance and translation in embryonic quail myocytes |
| Q36987868 | Mitogenic regulation of normal and malignant breast epithelium |
| Q69506654 | Modulation of actin mRNAs in cultured vascular cells by matrix components and TGF-beta 1 |
| Q72102339 | Modulation of schwann cell phenotype by TGF‐β1: Inhibition of P0 mRNA expression and downregulation of the low affinity NGF receptor |
| Q37223789 | Molecular Biology of Cytokine Effects on Vascular Endothelial Cells |
| Q90016328 | Molecular cloning and characteristics analysis of Pmtgfbr1 from Pinctada fucata martensii |
| Q39094397 | Molecular mechanism of sarcopenia and cachexia: recent research advances. |
| Q33817716 | Multiple tissue interactions and signal transduction pathways control somite myogenesis. |
| Q35032884 | Multistep process of squamous differentiation in tracheobronchial epithelial cells in vitro: analogy with epidermal differentiation |
| Q34031843 | Mutations in protein-binding hot-spots on the hub protein Smad3 differentially affect its protein interactions and Smad3-regulated gene expression |
| Q34578181 | MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. |
| Q28506896 | MyoD is indispensable for muscle-specific alternative splicing in mouse mitochondrial ATP synthase gamma-subunit pre-mRNA |
| Q35833803 | Myogenesis in thymic transplants in the severe combined immunodeficient mouse model of myasthenia gravis. Differentiation of thymic myoid cells into striated muscle cells |
| Q36791218 | Myogenic differentiation potential of human tonsil-derived mesenchymal stem cells and their potential for use to promote skeletal muscle regeneration |
| Q41683638 | Novel 150- and 180-kDa glycoproteins that bind transforming growth factor (TGF)-beta 1 but not TGF-beta 2 are present in several cell lines |
| Q37677477 | Orthopedic Manifestations of Type I Camurati-Engelmann Disease |
| Q36028460 | PED/PEA-15 induces autophagy and mediates TGF-beta1 effect on muscle cell differentiation |
| Q36233183 | Parallel regulation of procollagen I and colligin, a collagen-binding protein and a member of the serine protease inhibitor family |
| Q28594352 | Participation of multiple factors, including proliferin, in the inhibition of myogenic differentiation |
| Q34243039 | Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes |
| Q36731232 | Phorbol esters selectively and reversibly inhibit a subset of myofibrillar genes responsible for the ongoing differentiation program of chick skeletal myotubes |
| Q42756003 | Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds |
| Q35211526 | Platelet-rich plasma and skeletal muscle healing: a molecular analysis of the early phases of the regeneration process in an experimental animal model. |
| Q90146827 | Platelet-rich plasma does not reduce skeletal muscle fibrosis after distraction osteogenesis |
| Q35094973 | Platelet-rich plasma, especially when combined with a TGF-β inhibitor promotes proliferation, viability and myogenic differentiation of myoblasts in vitro |
| Q41367986 | Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation |
| Q36219542 | Posttranscriptional control of embryonic rat skeletal muscle protein synthesis. Control at the level of translation by endogenous RNA |
| Q33642619 | Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators |
| Q28568024 | Purification of the transforming growth factor-beta (TGF-beta) binding proteoglycan betaglycan |
| Q72087334 | RNA and protein localisations of TGFβ2 in the early mouse embryo suggest an involvement in cardiac development |
| Q41686112 | Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro |
| Q41699660 | Recombinant platelet-derived growth factor-BB stimulates growth and inhibits differentiation of rat L6 myoblasts |
| Q36818686 | Reduced expression of AP27 protein, the product of a growth factor-repressible gene, is associated with diminished adipocyte differentiation |
| Q37888538 | Regeneration of skeletal muscle. |
| Q35225874 | Regulation of Muscle Cell Growth and Differentiation by the Myod Family of Helix-Loop-Helix Proteins |
| Q34164622 | Regulation of MyoD function in the dividing myoblast |
| Q41648060 | Regulation of amphiregulin mRNA by TGF-beta in the human lung adenocarcinoma cell line A549 |
| Q34391396 | Regulation of myogenic activation of p38 MAPK by TACE-mediated TNFα release |
| Q37125927 | Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways |
| Q40671444 | Regulation of platelet-derived growth factor gene expression by transforming growth factor beta and phorbol ester in human leukemia cell lines |
| Q67698447 | Regulation of rat proximal tubule epithelial cell growth by fibroblast growth factors, insulin-like growth factor-1 and transforming growth factor-?, and analysis of fibroblast growth factors in rat kidney |
| Q37474961 | Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene |
| Q35426456 | Retinoic acid promotes myogenesis in myoblasts by antagonizing transforming growth factor-beta signaling via C/EBPβ |
| Q38096495 | Role of proteoglycans in the regulation of the skeletal muscle fibrotic response. |
| Q38777185 | Role of transforming growth factor beta in bone remodeling: a review |
| Q36217216 | Role of transforming growth factor-beta in the development of the mouse embryo |
| Q36327607 | Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation |
| Q34682407 | Sca-1 is negatively regulated by TGF-beta1 in myogenic cells |
| Q36726663 | Secretion and transcriptional regulation of transforming growth factor-beta 3 during myogenesis |
| Q38805063 | Secretome Analysis of Skeletal Myogenesis Using SILAC and Shotgun Proteomics |
| Q33867386 | Serum and transforming growth factor beta regulate glial fibrillary acidic protein in serum-free-derived mouse embryo cells |
| Q37618669 | Shared signaling systems in myeloid cell-mediated muscle regeneration |
| Q47566390 | Significant Improvement of Clinical Symptoms, Bone Lesions, and Bone Turnover after Long-Term Zoledronic Acid Treatment in Patients with a Severe Form of Camurati-Engelmann Disease |
| Q51066789 | Skeletal Muscle as an Endocrine Organ: The Role of Myokines in Exercise Adaptations. |
| Q38409230 | Smad7 promotes and enhances skeletal muscle differentiation |
| Q35591035 | Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation |
| Q36217584 | Some recent advances in the chemistry and biology of transforming growth factor-beta |
| Q36455038 | Spanish Consensus Statement: The Treatment of Muscle Tears in Sport. |
| Q47287508 | Spatial influence on breast muscle morphological structure, myofiber size, and gene expression associated with the wooden breast myopathy in broilers |
| Q38273056 | Stem cells for cardiac regeneration and possible roles of the transforming growth factor-β superfamily |
| Q40634530 | Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD. |
| Q28364253 | TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3 |
| Q37886466 | TGF-beta receptors and TGF-beta binding proteoglycans: recent progress in identifying their functional properties |
| Q43062779 | TGF-beta receptors, in a Smad-independent manner, are required for terminal skeletal muscle differentiation |
| Q34799828 | TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. |
| Q39911546 | TGF-beta's delay skeletal muscle progenitor cell differentiation in an isoform-independent manner |
| Q40573337 | TGF-beta-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation |
| Q52204225 | TGF-betas upregulate NCAM and L1 expression in cultured Schwann cells, suppress cyclic AMP-induced expression of O4 and galactocerebroside, and are widely expressed in cells of the Schwann cell lineage in vivo. |
| Q39308262 | TGF-β Family Signaling in Mesenchymal Differentiation |
| Q34943015 | TGF-β Inhibits Muscle Differentiation by Blocking Autocrine Signaling Pathways Initiated by IGF-II |
| Q89633958 | TGF-β Regulates Collagen Type I Expression in Myoblasts and Myotubes via Transient Ctgf and Fgf-2 Expression |
| Q38824306 | TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology |
| Q28274611 | TGF-β family signaling in stem cells |
| Q90661491 | TGF-β-driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model |
| Q35758216 | TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members |
| Q39644407 | TIEG1 negatively controls the myoblast pool indispensable for fusion during myogenic differentiation of C2C12 cells. |
| Q34193341 | Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis |
| Q44878942 | Temporal expression of growth factor genes during myogenesis of satellite cells derived from the biceps femoris and pectoralis major muscles of the chicken |
| Q40571488 | Terminal differentiation of Sol 8 myoblasts is retarded by a transforming growth factor-beta autocrine regulatory loop |
| Q36686910 | Testosterone improves the regeneration of old and young mouse skeletal muscle |
| Q37097926 | The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome. |
| Q38784881 | The TGF-β Signalling Network in Muscle Development, Adaptation and Disease. |
| Q28582320 | The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in viv |
| Q41119700 | The anti-cancer agent distamycin A displaces essential transcription factors and selectively inhibits myogenic differentiation |
| Q37900029 | The beta-type transforming growth factor. Mediators of cell regulation in the lung |
| Q37304093 | The inflammatory response to skeletal muscle injury: illuminating complexities. |
| Q39123630 | The influence of platelet-rich plasma on myogenic differentiation. |
| Q52200075 | The liver in transforming growth factor-Beta-1 (TGF-beta 1) null mutant mice. |
| Q36841835 | The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation |
| Q39062904 | The role of TGF-β1 during skeletal muscle regeneration. |
| Q24313061 | The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands |
| Q24674746 | Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism |
| Q52578165 | Tissue Expression Analysis and Characterization of Smad3 Promoter in Bovine Myoblasts and Preadipocytes. |
| Q37712825 | Towards understanding skeletal muscle regeneration |
| Q91899651 | Toxoplasma gondii Impairs Myogenesis in vitro, With Changes in Myogenic Regulatory Factors, Altered Host Cell Proliferation and Secretory Profile |
| Q24642495 | Transcription of the muscle regulatory gene Myf4 is regulated by serum components, peptide growth factors and signaling pathways involving G proteins |
| Q28576567 | Transforming growth factor beta (TGF-beta) signaling is regulated by electrical activity in skeletal muscle cells. TGF-beta type I receptor is transcriptionally regulated by myotube excitability |
| Q42026748 | Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase |
| Q33553280 | Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability |
| Q37047765 | Transforming growth factor beta induces myoblast differentiation in the presence of mitogens |
| Q33557263 | Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation |
| Q37499563 | Transforming growth factor beta represses the actions of myogenin through a mechanism independent of DNA binding |
| Q35866322 | Transforming growth factor beta1 induces differentiation in human papillomavirus-positive keratinocytes |
| Q39185363 | Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle. |
| Q52228214 | Transforming growth factor-beta in the early mouse embryo: implications for the regulation of muscle formation and implantation. |
| Q34568780 | Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts |
| Q69052955 | Transforming growth factor-beta inhibits cellular adenylate cyclase activity in cultured human arterial endothelial cells |
| Q24338700 | Transforming growth factor-beta-independent regulation of myogenesis by SnoN sumoylation |
| Q36649628 | Transforming growth factor-beta-regulated miR-24 promotes skeletal muscle differentiation |
| Q37922165 | Transforming growth factor-beta. Major role in regulation of extracellular matrix |
| Q35096079 | Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis |
| Q47744629 | Transforming growth factor-ßs as modulators of pericellular proteolytic events |
| Q47744635 | Transforming growth factor-β receptors |
| Q39573228 | Transforming growth factors in the regulation of malignant cell growth and invasion |
| Q40649958 | Tumor necrosis factor inhibits human myogenesis in vitro |
| Q40671327 | Type 1 transforming growth factor beta: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells |
| Q47073594 | Up-regulation of muscle-specific transcription factors during embryonic somitogenesis of zebrafish (Danio rerio) by knock-down of myostatin-1. |
| Q36505898 | Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination |
| Q73502326 | Variation in Response to Growth Factor Stimuli in Satellite Cell Populations |
| Q38135328 | Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis |
| Q28589107 | c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases |
| Q30421569 | miR-26a is required for skeletal muscle differentiation and regeneration in mice |
| Q35952729 | miR-431 promotes differentiation and regeneration of old skeletal muscle by targeting Smad4. |
Search more.